SURFACE ONCOLOGY INC (SURF)

US86877M2098 - Common Stock

1.07  -0.01 (-0.93%)

After market: 1.07 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-6-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.0030.00M2.69M126.20M15.40M
Operating Expenses
86.15M91.87M78.70M64.60M72.70M
Research and Development
59.79M64.23M50.93M38.90M49.10M
Selling, General, and Administrative Expenses
26.36M27.64M27.77M25.70M23.60M
Operating Income
-86.15M-61.87M-76.01M61.50M-57.40M
Interest Income/Expense
-5.77M-3.15M-2.55M-2.20M2.60M
Other Income/Expense
2.65M1.43M74.00KN/AN/A
Income Before Taxes
-92.50M-63.59M-78.48M59.30M-54.80M
Net Income
-92.50M-63.59M-78.48M59.30M-54.80M
EBITDA
-83.17M-60.50M-74.44M63.17M-55.61M
 
Per Share Data
EPS Diluted Total Ops
-1.54-1.14-1.771.56-1.97
Non GAAP EPS
-1.53-1.07-1.771.47-1.97
 
Statistics
Profit Margin
N/A-211.95%-2920.92%46.99%-355.84%
Operating Profit Margin
N/A-206.23%-2828.92%48.73%-372.73%

All data in USD

Charts